Seeking Alpha

Shares in partners Alkermes (ALKS) and Amylin Pharmaceuticals (AMLN) will resume trading at 4:15...

Shares in partners Alkermes (ALKS) and Amylin Pharmaceuticals (AMLN) will resume trading at 4:15 p.m., after a halt this afternoon tied to the FDA's approval of their Bydureon weekly diabetes treatment. Updated 4:16 p.m.: ALKS +3.6% AH; AMLN +14.8% AH. Now for the tough part.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|